After two decades at the helm, G. Patrick Lynch is stepping down as chief executive of Northern Technologies International. The anti-corrosion manufacturer announced Tuesday that long-time company veteran Gautam Ramdas will assume the top role, marking a definitive shift in the leadership structure of the firm.
A $20 million milestone payment from Takeda Pharmaceuticals has triggered a strategic shift at Keros Therapeutics, as the clinical-stage biotech firm authorized a $5 million share repurchase program. The windfall follows the successful dosing of the first patient in the ELRiSE MDS clinical trial, which targets anemia treatments.
BJ's Wholesale Club Holdings is set to receive a $240 million windfall following the resolution of a long-standing antitrust battle over credit-card interchange fees. As a plaintiff in the class-action litigation, the retailer expects to record the pre-tax gain, net of legal costs, during its current fiscal third quarter.
Sarah Rubenstein is pivoting from her role as Clearway Energy’s chief financial officer to spearhead a major technological overhaul. Effective October 1, she will transition into the newly created position of head of the transformation office at the company’s controlling investor, Clearway Energy Group, focusing on automation and AI integration.
Jennifer Ryu will step into the role of chief financial officer at Xponential Fitness starting October 19, marking the end of a seven-month search for a permanent successor. Her appointment follows a period of interim leadership as the company navigates its latest phase of executive restructuring.
A 38% spike in avocado volume propelled Mission Produce to $450 million in third-quarter revenue, comfortably outpacing analyst expectations. While the company recorded a $6.5 million net loss due to one-time costs, the top-line growth signals a strong integration of its recent acquisition, Calavo Growers.
A 20% plunge in after-hours trading greeted ServiceTitan investors Tuesday, as the software provider projected third-quarter revenue that failed to clear Wall Street’s bar. The sharp decline drags the company’s stock performance further into the red, erasing gains following a quarter that otherwise showed narrowing losses and steady growth.
As geopolitical tensions flare across the Middle East, energy markets are reacting with heightened volatility. Crude oil futures spiked in early trading, driving a broad rally among energy sector equities and pushing refinery operators to record valuation peaks as the supply outlook remains increasingly uncertain for global investors.
Copper futures surged to historic highs this week, acting as a rare anchor for the materials sector even as broader market indices retreated. Supply chain disruptions and persistent infrastructure demand combined with speculative interest tied to the artificial intelligence boom to drive the metal's valuation to unprecedented territory.
Threats of a ban on Bombardier and sharp political critiques of Ford Motor’s foreign partnerships sent industrial shares into a slide today. While trade tensions with Canada and China rattled investors, the market found a fleeting floor as GE Aerospace committed $11.75 billion to acquire Consolidated Precision Products.
A wave of negative growth warnings and failed clinical data dragged health care stocks lower today, as investors reacted to operational disruptions and stagnant drug trials. The sector faced pressure from major medical-device manufacturers and pharmaceutical giants struggling to meet market expectations amid unforeseen supply and technical hurdles.
Higher oil and gasoline prices are finally gnawing at the resilience of the U.S. consumer, dragging down retail-linked stocks even as spending remains surprisingly steady. While broad economic indicators show endurance, localized weakness is spreading through sectors burdened by persistent inflation and the ongoing pressure of elevated mortgage rates.
Financial institutions faced a sharp sell-off today as yields on two-year and 10-year Treasury notes climbed to multiyear highs. This surge in borrowing costs rattled investor sentiment, casting a shadow over the sector despite a broader market performance that has defied recent seasonal downturns and geopolitical friction.
Investors dumped communications services stocks today as a broader retreat from high-risk assets swept through the markets. Despite the sector-wide downturn, a major infrastructure play emerged as Verizon and Corning unveiled a massive multi-year deal to expand the nation's high-density fiber optic network to bolster artificial intelligence growth.
A fresh wave of artificial intelligence dealmaking buoyed technology stocks during a session of volatile trading. While broader market uncertainty persists, strategic collaborations and pricing shifts among industry giants provided a necessary catalyst for growth, even as legal challenges emerged in the warehouse sector regarding worker rights.
Geopolitical tension in the Middle East has sent investors scrambling for safety, driving a sharp rotation into the utility sector. As the conflict involving Iran escalates, traders are abandoning high-growth assets in favor of power producers, viewing the industry as a reliable hedge against broader market volatility and uncertainty.
Paramount Skydance has formally requested that plaintiffs in two ongoing antitrust lawsuits post a financial bond to cover potential legal costs should the company prevail in court. The demand targets a coalition of state attorneys general and the Writers Guild of America, who are currently blocking the Warner Bros. Discovery acquisition.
A 32% collapse in Evommune’s share price followed Tuesday’s announcement that the company’s experimental drug, EVO756, failed to meet its primary and secondary endpoints in a Phase 2b trial for atopic dermatitis, marking a significant setback for the biotech firm’s pipeline development.
The U.S. Department of Defense has tapped Northrop Grumman Systems for a $4.8 billion contract aimed at bolstering military aircraft defenses. The deal focuses on the Common Infrared Countermeasure system, a sophisticated technology designed to neutralize incoming heat-seeking missiles by disrupting their guidance systems with precise laser fire.
Shares of InnovAge climbed 11% to $11.67 in after-hours trading, fueled by a fiscal year revenue outlook that comfortably outpaced Wall Street expectations. The healthcare provider’s optimistic guidance arrives on the heels of a significant turnaround, with the company shifting from heavy losses to profitability in the most recent quarter.
A coordinated wave of drone and missile strikes by Houthi rebels against Saudi Arabian energy infrastructure has sent oil prices toward the $100 threshold, triggering a broad sell-off in U.S. equities and pushing government bond yields to levels not seen since 2025.
A 9.9% share price drop greeted Braze on Tuesday, even as the marketing software firm beat earnings expectations and raised its full-year revenue forecast. The company reported a second-quarter loss of 17 cents per share, a notable improvement from the 26-cent loss recorded during the same period last year.
After a fifteen-year absence, David Bailey is returning to Staar Surgical to oversee the company’s commercial operations. The former executive, who previously led the lens manufacturer through a period of critical regulatory and product development milestones, steps back into the organization as chief commercial officer effective immediately.
A batch of cured Italian pork cheek is being pulled from shelves across nine states after routine federal testing identified the presence of Listeria monocytogenes. The recall involves 1,513 pounds of guanciale produced by Bome SRL, distributed through Prime Line Distributors and Ferrarini USA to retailers and food-service providers nationwide.
Shares of Sigma Lithium plunged 15% to $10.54 Tuesday afternoon after a preliminary Brazilian judicial ruling purportedly suspended the company’s environmental licenses. While the firm maintains its mining operations remain unaffected, the sudden legal development has wiped out a significant portion of its market value amid a broader 20% annual decline.
A 9% slide in Beam Therapeutics shares on Tuesday followed the release of trial results for BEAM-302, a treatment targeting alpha-1 antitrypsin deficiency. While the company maintains the drug possesses a favorable safety profile, investors reacted sharply to data that showed no numerical improvement over previous mid-study benchmarks.
Shares of Bloom Energy climbed 11% to $279.92 by midday Tuesday, extending a blistering rally that has seen the fuel-cell provider’s market value more than triple this year. The jump follows a late-week announcement from S&P Dow Jones Indices confirming the company’s upcoming promotion into the S&P 500 benchmark.
A bold revision of long-term growth projections propelled AMD shares 6% higher on Tuesday, as Chief Financial Officer Jean Hu signaled that the company’s total addressable market could reach $3 trillion by 2030. The updated outlook significantly eclipses the $2 trillion estimate provided by the chipmaker just months ago in July.
Four former warehouse employees have leveled a class-action lawsuit against Amazon, accusing the retail giant of firing them for requesting medically necessary accommodations. The plaintiffs claim the company systematically penalized pregnant workers by flagging them for time off-task and draining their unpaid leave balances for essential health-related breaks.
A 16% jump in share price to $29 marks a significant milestone for Orion Energy Systems, which has now nearly doubled its market value this year. This surge follows the company securing a second multi-million dollar contract to outfit a global hyperscaler’s data facility with its specialized lighting technology.
